The weakening growth trends in May that we discussed last month continued in June, according to cannabis data analytics firm BDSA. The comparisons to a year ago, when demand surged during the pandemic, have created challenges, with two states, Colorado and Oregon, seeing sales decline compared to then. Most of the markets saw a sequential decline, with some in excess of the 3.2% due to one less day in the month than in May. In this review, we will look at the markets one-by-one, beginning with the more mature Western markets and then concluding with the newer Eastern markets.
BDSA provides coverage for Arizona, California, Colorado, Nevada and Oregon. In April, growth ranged from -3%% in Colorado to 29% in Arizona compared to a year ago.
Arizona transitioned to adult-use in late January, but this is the third month that BDSA included adult-use sales. Total cannabis sales grew 29% to $117.9 million, with adult-use representing $53.7 million, down slightly from May. Medical cannabis sales fell 30% to $64 million. Sequentially, overall growth fell 7.1%, with medical falling 4% and adult-use decreasing 0.4%. Growth was strong across all categories, but the highest growth by far was in pre-rolls, which gained 184%.
Annual sales grew 13.8% to $331.8 million, down 5% from June and 7% from the record level in April. Flower expanded 8%, with low double-digit growth for ingestibles and concentrates, while pre-rolls expanded by more than 50%.
The mature market of Colorado, which has shown vigorous growth over the past year, declined 5% compared to a year ago. Last June, sales had grown 30.4%, so compared to two year ago, sales expanded 23.9% (11.3% compound growth). Sequentially, sales dropped 5.3% to $190.5 million.